The safety and efficacy of direct oral challenge in trimethoprim-sulfamethoxazole antibiotic allergy

Affiliations

• ¹ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Victoria, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Victoria, Australia. Electronic address: [email protected].
• ² Department of Medicine (St Vincent's Health), University of Melbourne, Fitzroy, Victoria, Australia.
• ³ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Victoria, Australia.
• ⁴ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Victoria, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Victoria, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
• ⁵ The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Victoria, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
• ⁶ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Victoria, Australia; Department of Critical Care, University of Melbourne, Victoria, Australia; Data Analytics Research and Evaluation Centre, Austin Health and University of Melbourne, Victoria, Australia.
• ⁷ Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Victoria, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Victoria, Australia; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Medicine (Austin Health), University of Melbourne, Victoria, Australia.